Premarin vs. Bijuve

See how Premarin and Bijuve compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Premarin is an estrogen-only tablet approved for several conditions beyond menopause, while Bijuve combines estrogen and progesterone in one capsule for hot flashes only.

  • Women with a uterus taking Premarin usually need a separate progestin to protect the uterus, while Bijuve already contains progesterone in each dose.

  • Both drugs carry boxed warnings for blood clots, stroke, heart attack, dementia, and endometrial or breast cancer risk with hormone therapy.

Premarin vs. Bijuve Drug Summary

Premarin

Premarin is an estrogen hormone therapy made from conjugated estrogens, taken as a once-daily oral tablet. It treats menopausal hot flashes, vaginal atrophy, and several other estrogen-deficiency conditions, and is also used to slow bone loss after menopause. It has been FDA-approved since 1942 and comes in six tablet strengths.

Bijuve

Bijuve is a combination hormone therapy capsule containing bioidentical estradiol and micronized progesterone, taken once daily by mouth. It is FDA-approved only for moderate to severe hot flashes in menopausal women who still have a uterus. Approved in 2018, it comes in two capsule strengths and pairs estrogen with built-in endometrial protection.

Premarin vs. Bijuve Side Effects

Premarin

Most common
Breast pain/tenderness (common)
Headache (common)
Nausea (common)
Vomiting (common)

Bijuve

Most common
Breast tenderness (up to 10.4%)
Headache (up to 3.4%)
Vaginal bleeding (up to 3.4%)
Vaginal discharge (up to 3.4%)

Premarin vs. Bijuve Dosage

Premarin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.3 mg once daily At the start
Maximum dose 0.3 mg once daily Same as starting
Dose changes None Fixed dose

Bijuve

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg/100 mg once daily At the start
Maximum dose 0.5 mg/100 mg once daily Same as starting
Dose changes None Fixed dose

Premarin vs. Bijuve Indications

Premarin

Premarin is approved for a wide range of estrogen-related conditions, from menopausal hot flashes and vaginal atrophy to bone loss prevention and certain hormone-sensitive cancers. It is not approved to prevent heart disease or dementia, despite being one of the oldest estrogen products on the market. Doctors often prescribe it alongside a separate progestin for women who still have a uterus.

  • Moderate to severe hot flashes from menopause

  • Vaginal atrophy due to menopause

  • Prevention of postmenopausal osteoporosis

  • Hypoestrogenism from ovarian failure or hypogonadism

Bijuve

Bijuve is approved only for moderate to severe hot flashes in menopausal women who have a uterus. It is not approved for women without a uterus or for preventing heart disease, stroke, or dementia. Because it already contains progesterone, it is not paired with a separate progestin like estrogen-only products are.

  • Moderate to severe hot flashes from menopause

  • Only for women with a uterus

  • Combines estrogen and progesterone in one capsule

  • Not approved for osteoporosis or other estrogen uses

Premarin vs. Bijuve Pros and Cons

Premarin

Premarin has decades of clinical use and FDA approval for more conditions than Bijuve, including osteoporosis prevention and certain hormone-sensitive cancers. It comes in six tablet strengths, allowing finer dose adjustments than newer products. Because it contains estrogen only, women with a uterus typically need to add a separate progestin.

Pros

  • Approved for more conditions than Bijuve, including osteoporosis

  • Six tablet strengths allow precise dose adjustments

  • Available in oral tablet or vaginal cream form

Cons

  • Requires a separate progestin for women with a uterus

  • No FDA-approved generic version available

  • Made from conjugated estrogens rather than bioidentical hormones

Bijuve

Bijuve combines bioidentical estradiol and progesterone in a single daily capsule, so women with a uterus do not need to add a separate progestin. It is a newer option with a narrower FDA approval, limited to treating hot flashes. Its dosing is simpler, with only two capsule strengths to choose from.

Pros

  • Built-in progesterone protects the uterus without a second pill

  • Uses bioidentical estradiol and progesterone

  • Simple two-strength dosing

Cons

  • Approved only for hot flashes, not osteoporosis or other uses

  • Cannot be used by women without a uterus

  • Fewer years of real-world use than Premarin

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.